Novel biologics in inflammatory bowel disease

被引：16
|
作者：
Papachristou, GI [1 ]
Plevy, S [1 ]
机构：
[1] Univ Pittsburgh, Sch Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15261 USA
来源：
GASTROENTEROLOGY CLINICS OF NORTH AMERICA | 2004年 / 33卷 / 02期
关键词：
D O I：
10.1016/j.gtc.2004.02.007
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Understanding of immunologic mechanisms involved in the initiation and perpetuation of chronic inflammation has led to new therapeutic opportunities in the inflammatory bowel diseases. The term "biologics" is used to distinguish new biotechnologic therapeutics from the conventional drugs used in the treatment of immune-mediated inflammatory disorders. This article reviews novel biologic therapies that are being investigated for the treatment of Crohn's disease and ulcerative colitis.
引用
收藏
页码：251 / +
页数：20
相关论文
共 50 条
  • [41] Positioning biologics and new therapies in the management of inflammatory bowel disease
    Honap, Sailish
    Cunningham, Georgina
    Tamilarasan, Aravind Gokul
    Irving, Peter M.
    CURRENT OPINION IN GASTROENTEROLOGY, 2019, 35 (04) : 296 - 301
  • [42] Healthcare Utilization of Elderly Patients With Inflammatory Bowel Disease on Biologics
    Iyengar, Meera
    Billings, Wade
    Bohm, Matthew
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S897 - S898
  • [43] New biologics and small molecules in inflammatory bowel disease: an update
    Sabin, Joao
    Verstockt, Bram
    Vermeire, Severine
    Ferrante, Marc
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2019, 12
  • [44] The risk for opportunistic infections in inflammatory bowel disease with biologics: an update
    Borman, Zachary A.
    Cote-Daigneault, Justin
    Colombel, Jean-Frederic
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 12 (11) : 1101 - 1108
  • [45] USE OF BIOLOGICS IN INFLAMMATORY BOWEL DISEASE PATIENTS ON CHEMOTHERAPY FOR CANCER
    Koduru, Pramoda
    Abraham, Bincy P.
    INFLAMMATORY BOWEL DISEASES, 2018, 24 : S80 - S80
  • [46] Safety considerations with biologics and new inflammatory bowel disease therapies
    Queiroz, Natalia S. F.
    Regueiro, Miguel
    CURRENT OPINION IN GASTROENTEROLOGY, 2020, 36 (04) : 257 - 264
  • [47] CLINICAL RESPONSE TO THE NEWER BIOLOGICS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
    Hudacek, Noah
    Bennett, William E.
    Pfefferkorn, Marian D.
    GASTROENTEROLOGY, 2023, 164 (06) : S1131 - S1132
  • [48] Drug Clearance in Patients with Inflammatory Bowel Disease Treated with Biologics
    Deyhim, Tina
    Cheifetz, Adam S.
    Papamichael, Konstantinos
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (22)
  • [49] Trends in the Utilization of Biologics for Inflammatory Bowel Disease in the United States
    Chen, Chao
    Hartzema, Abraham
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 274 - 274
  • [50] USE OF BIOLOGICS IN INFLAMMATORY BOWEL DISEASE PATIENTS ON CHEMOTHERAPY FOR CANCER
    Koduru, Pramoda
    Abraham, Bincy P.
    GASTROENTEROLOGY, 2018, 154 (01) : S113 - S113
12345